Children's vision develops. Different parts of the visual system come online on their own schedules, and contrast sensitivity is one of the slower ones. Acuity catches up first, and it is what standard pediatric eye exams check most carefully. Contrast sensitivity — the broader functional measurement that complements acuity — is rarely tested in children, though the developmental story has been studied since the late 1970s.
This post is for parents and for clinicians who find our test and want to know what the literature actually says. Children are not our primary audience, and the test is not designed for them. The short version: take a child with any vision concern to a pediatric ophthalmologist or pediatric optometrist. The longer version is below.
How contrast sensitivity develops
Adult contrast sensitivity is not present at birth, nor at school age. It arrives in stages, with the low-spatial-frequency (coarse-pattern) end maturing earlier than the high-spatial-frequency (fine-detail) end.
Infancy. Behavioral measurements using forced-choice preferential looking — the experimenter shows the infant a striped pattern on one side and a uniform gray field on the other, and infers detection from which side the infant fixates — established that infant contrast sensitivity is markedly lower than adult and rises rapidly over the first three months. Atkinson, Braddick & Moar (1977) measured CSFs in 1–3-month-olds and showed sensitivity climbing by roughly an order of magnitude, with the peak shifting toward higher spatial frequencies as the infant aged. Norcia & Tyler (1985), using the sweep visually-evoked-potential technique — recording a brain response to a swept grating, no behavioral report required — measured 197 infants between 1 and 53 weeks and found grating acuity rising from about 4.5 cycles per degree in the first month to roughly 20 cpd by 8–13 months. (Adult acuity is about 30–60 cpd.)
Toddlers and preschoolers through school age. Behavioral CSF measurement remains difficult — attention is the limiting factor more than vision. The low-frequency end reaches adult levels relatively early; the high-frequency end keeps maturing. Ellemberg, Lewis, Liu & Maurer (1999) measured CSFs at low spatial frequencies (0.25 to 2 cpd) in 4-, 5-, 6-, and 7-year-olds and adults; they found a roughly half-log-unit increase between ages 4 and 7, at which point low-frequency sensitivity was indistinguishable from adult. Reviews place the age of fully adult-shaped CSFs somewhere between 7 and 19 years depending on spatial frequency, test, and criterion.
A "normal CSF" in a four-year-old does not look the same as in a twenty-four-year-old. This is why pediatric vision testing uses age-specific tools — preferential looking cards (Teller), HOTV or LEA symbol charts, Cardiff cards — rather than the Snellen line adults read.
Amblyopia: where contrast sensitivity shows up clinically
The pediatric vision condition with the longest CSF research history is amblyopia — often called "lazy eye," the developmental condition in which one eye does not develop normal vision during the critical period, usually because of strabismus (misalignment), anisometropia (a refractive-error difference between the eyes), or, less commonly, deprivation (cataract or other obstruction during infancy). Amblyopia is the leading cause of monocular reduced vision in children, with prevalence in the 1–4% range.
The classic finding is that the amblyopic eye has reduced contrast sensitivity, with a pattern informative about the subtype. Hess & Howell (1977), in a foundational Vision Research paper, measured CSFs in strabismic amblyopes and described two patterns: one with reduced sensitivity primarily at high spatial frequencies (mirroring the acuity loss), another reduced across all spatial frequencies including low ones — a broader deficit suggesting amblyopia is not just a high-frequency story. Later work on anisometropic and mixed-mechanism amblyopia reinforced the finding: the amblyopic eye is contrast-deficient, often more so than acuity loss alone would predict, with deficit shape varying by subtype.
Treatment. Standard treatment is patching (occluding the better eye for hours per day) or atropine penalisation (blurring the better eye pharmacologically). The Pediatric Eye Disease Investigator Group (PEDIG) has run large multicentre trials establishing dose–response for patching and confirming atropine as an alternative in moderate amblyopia. Contrast sensitivity in the amblyopic eye improves alongside acuity during successful treatment, and residual deficits can persist even when post-treatment acuity looks reasonable — one reason "20/20 at the end of treatment" is not the only outcome that counts.
None of this means a child with suspected amblyopia should be assessed at home. Amblyopia is diagnosed and managed by pediatric eye-care specialists using age-appropriate acuity testing, cycloplegic refraction, and cover-uncover testing. The relevance of the CSF story is that contrast sensitivity reveals deficits acuity alone can miss, supporting thorough follow-up — not self-testing.
Other pediatric conditions where CSF matters
Contrast sensitivity is reduced in a number of other pediatric ocular and neurological conditions. None are diagnosed by an at-home test; the relevance is that the functional impact is broader than acuity alone implies.
- Uncorrected high refractive error — significant uncorrected myopia, hyperopia, or astigmatism degrades high-frequency contrast sensitivity, which corrected lenses largely fix.
- Pediatric cataract — congenital and developmental cataracts cause intraocular scatter that reduces contrast sensitivity across the curve; outcomes improve with early surgery during the critical period.
- Optic nerve hypoplasia — congenital underdevelopment of the optic nerve, variably affecting contrast sensitivity, often part of a broader neuro-ophthalmologic picture.
- Cortical / cerebral visual impairment (CVI) — visual dysfunction from damage to visual pathways or cortex rather than the eye itself. Children with CVI often show reduced contrast sensitivity along with characteristic visual-behavior patterns.
- Genetic retinal dystrophies — conditions like retinitis pigmentosa, cone-rod dystrophy, and Stargardt disease typically reduce contrast sensitivity early in their natural history, sometimes before acuity drops to clearly abnormal.
In each of these, contrast sensitivity is a real functional impact and a real research outcome — but not the diagnostic tool. The diagnostic work is clinical.
What an online test can and cannot do in pediatrics
Our test is an adaptive grating measurement designed for adults at a known viewing distance with calibrated screen contrast, holding attention for several minutes and responding to a forced-choice tilt task. Those assumptions matter when thinking about whether it is appropriate for a child.
Older children (roughly 10+) with good attention can take the test the way an adult does. The task is simple — tell which way the stripes lean — and a motivated tween or teenager can complete it. Numbers are interpretable in the same age-normative framework as adults, with the caveat that high-frequency sensitivity may still be maturing in early adolescence.
Younger children. Standard pediatric clinic tests (Teller cards, HOTV, LEA symbols, age-appropriate CSF charts) are validated for the age and have known normative bands. Our test is not validated for any pediatric age group. An attempt to administer it to a four-year-old will mostly measure their tolerance for sitting still and pressing arrow keys.
Online tests for kids are noisy. Attention drifts faster, viewing distance and screen calibration are harder to enforce, and a single bad run can shift the result without anyone noticing. The signal-to-noise an in-clinic pediatric test achieves is hard to match at home.
What we do not recommend
Some specific things this test is not for, when it comes to children:
Do not use this test in place of a pediatric eye exam. Vision screening in early childhood — for amblyopia, refractive error, strabismus, and rarer conditions — is part of standard pediatric care from infancy through school age. The American Academy of Pediatrics, the American Academy of Ophthalmology, and the American Association for Pediatric Ophthalmology and Strabismus all publish screening recommendations. None are replaced by an at-home test.
Do not use this test to monitor amblyopia treatment. Patching, atropine, and binocular-vision-based therapies are monitored by the prescribing clinician. An unsupervised home grating test is too variable and not validated for the role.
Do not read too much into a single result from a young child. A single CSF measurement on an adult is already a snapshot — the smallest clinically meaningful change on a well-validated chart is about 0.3 log units. In a child the snapshot is noisier, the normative comparison is age-dependent, and the most likely explanation for a low reading is the testing situation, not the child's eyes.
When CSF might be useful for an older child or adolescent
A few situations exist where an older child or adolescent — testing voluntarily, alongside clinical care — might find a CSF measurement informative.
Post-concussion symptoms in an adolescent. Concussion can produce vision changes that show up on CSF testing even when acuity is unremarkable; see post-concussion vision changes and the week-by-week recovery guide. Both posts are written for adults, but the physiology applies to adolescents, and an older teenager whose clinician is tracking recovery may find a same-setup baseline-and-followup pair useful — as a complement to care, not a substitute.
Tracking a known condition in a teen. A teenager already in care for a vision-affecting condition — early-onset MS with optic-neuritis history, a managed retinal condition, a post-cataract-surgery follow-up — may, with their specialist's awareness, use the test for a between-visits trend line. Same caveats as adults: same screen, same lighting; the trend matters more than any single number.
Curiosity or science-class context. A teenager who wants to see their own CSF curve, or who is learning about psychophysics in school, can take the test for its own sake. The result is theirs to share with a clinician if anything looks off.
In all three cases, the test is paired with clinical care, not a replacement.
What our test cannot do for children
A single screening on a young child means very little. The task assumes adult attention, adult reading-distance behavior, and adult comprehension of "press left if the stripes lean left." None of those assumptions hold reliably under age ten.
Our privacy policy says the service is not intended for users under 13. That reflects two considerations. First, regulatory and analytics: the laws around information collection about children online (COPPA in the US, similar elsewhere) make running an account/analytics product for under-13s a different undertaking; we follow the standard cutoff. Second, psychophysical: the test is built for an adult observer, and a young child taking it casually generates data that reflects the testing situation more than their vision. Both are real; neither is about the test's technical operability.
An older child taking the test once, with a parent present, in the context of a clinical question someone is already pursuing, is different from running a young child through it as a screen. The first can be useful in context; the second is unlikely to help.
If you have a child with vision concerns
The right next step is a pediatric ophthalmologist or pediatric optometrist. Routine vision screening is part of well-child care; if your child shows warning signs — squinting, head tilting, sitting unusually close to screens, headaches with reading, an eye that drifts, a noticed difference between the eyes, or a family history of childhood eye conditions — a specialist evaluation is the right step, not an online test. Our test is for adolescents and adults; even for them, it is a screening signal and a tracking tool, not a substitute for clinical care.
If you are an adolescent or adult curious about your own contrast sensitivity, take the test in your browser. The result stays on your device unless you choose to share it.
References
- Atkinson, J., Braddick, O., & Moar, K. (1977). Development of contrast sensitivity over the first 3 months of life in the human infant. Vision Research, 17(9), 1037–1044. Foundational behavioral study of rapid infant CSF development in the first three months.
- Norcia, A. M., & Tyler, C. W. (1985). Spatial frequency sweep VEP: visual acuity during the first year of life. Vision Research, 25(10), 1399–1408. Sweep-VEP measurements of grating acuity in 197 infants from 1 to 53 weeks of age.
- Ellemberg, D., Lewis, T. L., Liu, C. H., & Maurer, D. (1999). Development of spatial and temporal vision during childhood. Vision Research, 39(14), 2325–2333. Low-frequency CSF in 4-, 5-, 6-, and 7-year-olds; sensitivity reached adult levels by age 7.
- Hess, R. F., & Howell, E. R. (1977). The threshold contrast sensitivity function in strabismic amblyopia: evidence for a two-type classification. Vision Research, 17(9), 1049–1055. Foundational paper distinguishing CSF deficit subtypes in strabismic amblyopia.
- Pelli, D. G., Robson, J. G., & Wilkins, A. J. (1988). The design of a new letter chart for measuring contrast sensitivity. Clinical Vision Sciences, 2, 187–199. Methodological anchor for clinical CS testing; source for test-retest variance and minimum clinically meaningful change.